Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosbretabulin in PNET or GI-NET
NCT02132468Phase 2Completed
- Sponsor
- Oncotelic Therapeutics, Inc.
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosbretabulin in Pancreatic neuroendocrine tumor (PanNET), gastrointestinal neuroendocrine tumor, sponsored by Oncotelic Therapeutics, Inc.. Started Sep 2014; status: completed.
02
Drugs
fosbretabulin
03
Conditions
Pancreatic neuroendocrine tumor (PanNET)gastrointestinal neuroendocrine tumor
Beyond the preview
Go deeper on NCT02132468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132468.